High Co-Payments Associated With Delay In Starting Drug Therapy In Patients With Chronic Diseases

High co-payments are associated with delayed initiation of medication in patients with newly diagnosed hypertension, diabetes and elevated cholesterol levels, according to a report in the April 27 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Rising prescription drug costs in the past decade have caused more restrictive insurance benefits, including an increase in cost sharing (i.e.

More: continued here

Filed under: Cholesterol on May 3rd, 2009